Marijke Spooren
Partner
Chambers Global
“A ‘brilliant lawyer,’ according to interviewees, who highlight her academic ability. She represents clients in substantial cross-border transactions in the life sciences and automotive industries.”
The Legal 500 EMEA
“Marijke Spooren is an exceptional rising talent. Young partner with the experience and the judgement of an industry veteran.”
Law.com International
“Marijke Spooren is making her name as a skilled, dynamic negotiator with a talent for leading teams on complex deals.”
Marijke Spooren’s practice focuses on corporate law, mergers and acquisitions, private equity investments, and capital markets transactions.
Marijke represents buyers and sellers in domestic and international M&A transactions, and issuers and underwriters in equity offerings. She regularly advises companies on corporate and securities law questions, including governance, disclosure, shareholder activism, and market abuse matters. Marijke also has experience in selected regulated sectors.
Marijke joined the firm in 2012 and became a partner in 2022. From 2014 to 2015, she was resident in the New York office.
Notable Experience
Selected Corporate/M&A Experience
-
Abbott Laboratories in the international aspects of the sale of Abbott Medical Optics to Johnson & Johnson.
-
Ahold Delhaize in its accession to Eurelec, alongside the French retailer E. Leclerc and the German retailer REWE.
-
Alpha Private Equity in connection with the acquisition of European insulation materials group Ipcom.
-
Atlantic Tele-Network in its acquisition of a controlling interest in KeyTech, a Bermuda company providing telecom services in Bermuda and the Cayman Islands.
-
Bekaert in the sale of its steel wire joint venture in Chile and Peru, and its buy-out of Ontario Teachers’ Pension Plan (OTPP)’s equity stake in the Bridon-Bekaert Ropes Group.
-
bpost in several transactions, including its ultimately abandoned (friendly) takeover bid on PostNL and the sale of its stake in bpost bank to JV partner BNPPF.
-
Collibra on the redomiciliation of its parent entity from Belgium to the Netherlands.
-
CVC Capital Partners Limited in its acquisition of the European activities of the Campbell Soup Company.
-
Dexia in the sale of BIL.
-
D’Ieteren in connection with the sale of a minority interest in Belron to Clayton Dubilier & Rice and subsequent transactions.
-
The family shareholders of global blood management solutions software provider MAK-System, in the significant investment by The Carlyle Group in MAK-System.
-
Infinite Electronics, a Warburg Pincus portfolio company, in its acquisition of Cable Connectivity Group (CCG) from Torqx Capital Partners and TKH Group.
-
The Novasep group, a portfolio company of Silver Point Capital and Blackrock, in the sale of its viral vector business to Thermo Fisher and subsequent sale of its pharma solutions and process solutions businesses to PharmaZell, a portfolio company of Bridgepoint.
-
Ontex in several transactions, including its defense against the unsolicited bid by PAI Partners and in the €285 million divestment of its Mexican business to Softys.
-
Ottobock in its acquisition of V!GO International, a leading patient care company.
-
Universal Services of America, a portfolio company of Warburg Pincus, in its acquisition of the security business of ABM Industries Inc.
-
Western Digital Corporation in its acquisition of Amplidata, a developer of object storage software for public and private cloud data centers.
Selected Capital Markets Experience
-
The IPOs of Ontex and bpost.
-
Various (secured and unsecured) convertible bonds offerings by Bekaert and Nyrstar.
-
Senior notes offering by Nyrstar.
-
Secondary offering of common stock by Sabre Corporation and affiliates of TPG Global and Silver Lake Partners.
-
Secondary block trades of shareholders in Cofinimmo.
Selected Activities
triggerTeaching assistant of Corporate Law at the Katholieke Universiteit Leuven, 2017-2020
Voluntary scientific collaborator at the Katholieke Universiteit Leuven, 2012-2013
Publications
Events
-
November 28, 2023
-
June 9, 2022
Shareholder Activism in Belgium: Boon or Curse for Sustainable Value Creation?